Natural Capsules Share Price

Natural Capsules

CMP as on28-Jul-21 15:28

₹ 164.80
2.25 1.38%

Open

₹ 163.00

Turnover (lac)

₹ 2

Prev. Close

₹ 162.55

Day's Vol (shares)

₹ 3,421

Day's Range

₹ 161.00
₹ 167.40

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 15-Jul-2021 - -
Outcome of Board Meeting.
Board Meeting - 24-May-2021 - -
NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/05/2021 ,inter alia, to consider and approve Notice of 139th Board Meeting is scheduled on Monday, the 31st day of May 2021. Outcome of 139th Board Meeting held on May 31, 2021 Results - Financial Results for March 31, 2021 (Consolidated & Standalone) Recommended dividend of Rs.1 per equity share of Rs. 10/- each subject to the approval of the members. (As Per BSE Announcement Dated 31.05.2021) Natural Capsules Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 31, 2021, inter alia, have: 1. Recommended dividend of Re. 1 per equity share of Rs. 10/- each subject to the approval of the members. 2. Convening the 28th Annual General Meeting of the Company on July 15, 2021. (As Per BSE Announcement Dated 01.06.2021)
Board Meeting - 16-Jan-2021 - -
NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2021 ,inter alia, to consider and approve Unaudited standalone financial results and unaudited consolidated financial results of the Company for the Quarter ended December 31st 2020. Pursuant to and in compliance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with the policy / code of internal procedures and conduct for regulating, monitoring and reporting of trading by insiders of the Company, the trading window for directors and specified employees is already closed and it shall remain closed till the conclusion of 48 hours after the declaration of financial results of the Company. Board of Directors at their meeting held on 25.01.2021, inter alia has transacted the following: 1. Adoption of Standalone & Consolidated Unaudited Financial Results for the quarter Ended 31st December 2020. The meeting commenced at 1.00 PM and concluded at 3.15 PM. Board of Directors at their meeting held on 25.01.2021, inter alia has transacted the following: 1. Adoption of Standalone & Consolidated Unaudited Financial Results for the quarter Ended 31st December 2020. The meeting commenced at 1.00 PM and concluded at 3.15 PM. Kindly take the above information on records. With reference to the captioned subject, We hereby inform that, 1. Notice of 137th Meeting of Board of Directors has been published in Business Line-An English daily & Sanjevani- a Kannada daily; 2. Financial Results for the third quarter ended 31st December, 2020 has been published in Business Line-An English daily & Sanjevani- a Kannada daily. We enclose herewith the copies of Newspaper cuttings for your reference and records. (AS Per BSE Announcement Dated on 25.01.2021)
Board Meeting - 30-Oct-2020 - -
NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2020 ,inter alia, to consider and approve We wish to inform you that 136th meeting of the Board of Directors of the company is scheduled to be held on 7th day of November, 2020, inter alia to consider the following: To consider and approve unaudited standalone financial and unaudited consolidated financial results of the Company for the Quarter & half year ended September 30th 2020. Pursuant to and in compliance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with the policy / code of internal procedures and conduct for regulating, monitoring and reporting of trading by insiders of the Company, the trading window for directors and specified employees is already closed and it shall remain closed till the conclusion of 48 hours after the declaration of financial results of the Company. Board of Directors at their meeting held on 07.11.2020, inter alia has transacted the following: Adoption of Unaudited Standalone & Unaudited Consolidated Financial Results for the quarter & half year Ended 30th September, 2020. Further, in compliance with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we submit herewith, the unaudited standalone and consolidated financial results along Limited Review report for the Second quarter & half-year ended 30th September, 2020. The meeting commenced at 04.00 PM and concluded at 6.00 PM. Kindly take the above information on records. Sub: Addendum to Outcome Board Meeting: With reference to our letter dated 07.11.2020, regarding outcome of Board Meeting, we wish to inform that by oversight data mentioned in half ended columns of UNAUDITED CONSOLIDATED FINANCIAL RESULT FOR THE SIX MONTH ENDED SEPTEMBER, 2020 were incorrect, and now corrected statement is being filed. Kindly take the above information on records. (AS Per BSE Announcement Dated on 07.11.2020)
Board Meeting - 27-Aug-2020 - -
The Board of Directors at their meeting held on 27.08.2020, inter alia has transacted the following business:- In view of the various tax and other benefits available for a new industrial undertaking, the board decided to implement the proposed API (Active Pharma Ingredients) project in wholly owned subsidiary Natural Biogenex Private Limited. It was also agreed to transfer the leasehold land, earlier allotted to the Company by Karnataka Industrial Areas Development Board (KIADB), to the wholly owned subsidiary Natural Biogenex Private Limited for this purpose. The meeting commenced at 3.00 PM and concluded at 4.00 PM.
Board Meeting - 29-Jul-2020 - -
NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2020 ,inter alia, to consider and approve the Consolidated & Standalone Unaudited Financial Results of the Company for the Quarter ended 30th June, 2020. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Companys Code of Conduct for Prevention of Insider Trading and Code of Corporate Disclosure Practices, we wish to inform that the Trading Window for dealing in the equity shares of the Company has remained closed for all Designated Person and their immediate relatives w.e.f. 01st July 2020 till the conclusion of 48 hours after the declaration of financial results of the Company for the Quarter ended 30th June, 2020. Board of Directors at their meeting held on 07.08.20, inter alia has transacted the following: 1. Adoption of Standalone & Consolidated Unaudited Financial Results for the quarter Ended 30th June 2020. Further in compliance with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we submit herewith, the unaudited standalone and consolidated financial results along Limited Review report for the First quarter ended 30th June, 2020. We shall arrange to publish the unaudited financial results in the newspapers. (As per BSE Announcement Dated on 7/8/2020)
Open ZERO Brokerage Demat Account